Delivery Order SPE2DB20D3101-SPE2DB23FRAF7
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $2,629.21 firm fixed-price delivery order is for the procurement of Cyclosporine 0.05% eye emulsion, a specialty pharmaceutical product. The contract has a performance period that runs through December 29, 2023. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,534.29 firm fixed-price delivery order is for the supply of Cyclosporine 0.05% eye emulsion, a specialty pharmaceutical product. The contract has an ultimate completion date of March 8, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order (SPE2DB22FM67A) valued at $18,891.52 for the supply of cyclosporine 0.05% eye emulsion. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of August 4, 2022. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical, a significant customer of the prime contractor Amerisourcebergen Drug Corp. The $1,364.37 firm fixed price delivery order is for the supply of Cyclosporine 0.05% eye emulsion, a critical pharmaceutical product. Amerisourcebergen, a major pharmaceutical distributor, is leveraging its extensive supply chain to provide this medication to support military treatment programs and facilities. The...
- This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $3,950.49 delivery order is for Cyclosporine 0.05% eye emulsion, with a completion date of May 18, 2023. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,108.58 firm fixed price delivery order is for the procurement of Cyclosporine 0.05% eye emulsion, with a completion date of October 23, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,870.90 Firm Fixed Price Delivery Order is for the supply of Cyclosporine 0.05% Eye Emulsion, a specialized ophthalmic medication. The contract has an ultimate completion date of October 26, 2023 and was awarded on October 25, 2023. AmerisourceBergen holds a significant $999,999,999...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Cyclosporine 0.05% eye emulsion, a specialty medication, with a ceiling value of $1,088.96 and a period of performance through February 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order (SPE2DB23FLAE1) valued at $3,080.80 for the supply of Cyclosporine 0.05% eye emulsion. The award was made by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of May 3, 2023. The contract is not designated with a set-aside, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award, with an ID of SPE2DX15D3015|SPE2DX24F0FQ9, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Cyclosporine 0.05% eye emulsion, a pharmaceutical product. The award has a ceiling value of $3,244.48 and runs through February 29, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB23FRAF7Delivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of Cyclosporine 0.05% eye emulsion. The $1,611.54 firm fixed-price delivery order has a completion date of January 18, 2023 and was awarded on January 17, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract encompasses critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains. Additionally, Amerisourcebergen maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 1/17/23 |